After a year that has seen major changes for some of the biggest players in the global off-patent industry, it is perhaps no surprise that Generics Bulletin’s annual ranking of the world’s top 50 generics and biosimilars companies has reflected this upheaval.
This year, our annual ranking of the top 50 generics and biosimilars companies is being presented in three parts, and our initial look at the top 10 companies paints a picture that looks quite different to the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?